Randomized Clinical Trial of Axillary Lymphadenectomy Without Drainage for Breast Cancer Treatment
N/A
N/A
Female
Breast Cancer, Complications, Seroma
Trial Information
Randomized Clinical Trial of Axillary Lymphadenectomy Without Drainage for Breast Cancer Treatment
The primary objective is to study the safety of not draining the axilla, considering the
total number of patients without complication among breast cancer patients treated by means
of conservative surgery and full axillary lymphadenectomy, with or without axillary
drainage.
The secondary objectives will be the numbers of aspiration punctures, volumes of fluid
aspirated and the total volumes of fluid produced.
Inclusion Criteria:
- Stage I and II breast cancer patients
- Will be submitted to breast conserving therapy, with full axillary lymphadenectomy
Exclusion Criteria:
- diabetes
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Safety
Outcome Description:
The safety of not draining the axilla, will be considered by the total number of patients without complication among breast cancer patients treated by means of breast conserving surgery and full axillary lymphadenectomy
Outcome Time Frame:
6 months
Safety Issue:
Yes
Principal Investigator
Ruffo Freitas-Junior, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universidade Federal de Goias
Authority:
Brazil: Ethics Committee
Study ID:
Drains Trial
NCT ID:
NCT01267552
Start Date:
July 2000
Completion Date:
December 2007
Related Keywords:
- Breast Cancer
- Complications
- Seroma
- Breast cancer
- Surgery
- Complications
- Drainage
- Seroma
- Breast Neoplasms
- Seroma
Name | Location |
|---|
